Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Insider Sale: Chairman of $BSX Sells 1,200 Shares

Automated

Michael F Mahoney, the Chairman of $BSX, sold 1,200 shares of the company on 02-02-2026 for an estimated $112,868. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.1% of their shares of this class of stock. Following this trade, they now own 1,571,436 shares of this class of $BSX stock.

$BSX Insider Trading Activity

BSX Insider Trades

$BSX insiders have traded $BSX stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $BSX stock by insiders over the last 6 months:

  • JOSEPH MICHAEL FITZGERALD (EVP & Group Pres, Cardiology) has made 0 purchases and 7 sales selling 150,000 shares for an estimated $15,168,080.
  • MICHAEL F MAHONEY (Chairman, President & CEO) has made 0 purchases and 2 sales selling 160,901 shares for an estimated $15,043,394.
  • ELLEN M ZANE has made 0 purchases and 3 sales selling 25,782 shares for an estimated $2,573,877.
  • ARTHUR C BUTCHER (EVP& Grp Pres, MedSurg & APAC) sold 17,313 shares for an estimated $1,758,188

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$BSX Hedge Fund Activity

We have seen 867 institutional investors add shares of $BSX stock to their portfolio, and 786 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$BSX Revenue

BSX Quarterly Revenue

$BSX had revenues of $5.1B in Q3 2025. This is an increase of 20.34% from the same period in the prior year.

You can track BSX financials on Quiver Quantitative's BSX stock page.

$BSX Congressional Stock Trading

Members of Congress have traded $BSX stock 10 times in the past 6 months. Of those trades, 4 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $BSX stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$BSX Analyst Ratings

Wall Street analysts have issued reports on $BSX in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • RBC Capital issued a "Outperform" rating on 12/17/2025
  • BTIG issued a "Buy" rating on 11/21/2025
  • Truist Securities issued a "Buy" rating on 10/23/2025
  • UBS issued a "Buy" rating on 10/23/2025
  • Needham issued a "Buy" rating on 10/17/2025
  • Evercore ISI Group issued a "Outperform" rating on 10/07/2025
  • Canaccord Genuity issued a "Buy" rating on 10/01/2025

To track analyst ratings and price targets for $BSX, check out Quiver Quantitative's $BSX forecast page.

$BSX Price Targets

Multiple analysts have issued price targets for $BSX recently. We have seen 14 analysts offer price targets for $BSX in the last 6 months, with a median target of $126.5.

Here are some recent targets:

  • Matt Miksic from Barclays set a target price of $124.0 on 02/03/2026
  • Suraj Kalia from Oppenheimer set a target price of $100.0 on 01/16/2026
  • Richard Newitter from Truist Securities set a target price of $120.0 on 12/18/2025
  • William Plovanic from Canaccord Genuity set a target price of $131.0 on 12/17/2025
  • Shagun Singh from RBC Capital set a target price of $130.0 on 12/17/2025
  • Marie Thibault from BTIG set a target price of $132.0 on 11/21/2025
  • Larry Biegelsen from Wells Fargo set a target price of $125.0 on 10/23/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles